Skip to main content

AstraZeneca tops FTSE 100 leaderboard as U.K. stocks underperform Europe

Shares of AstraZeneca rose as much as 7% on signs of progress on a key lung cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.